A Japan nationwide web-based survey of patient preference for renal denervation for hypertension treatment

Kario, Kazuomi; Kagitani, Hideaki; Hayashi, Sueko; Hanamura, Satsuki; Ozawa, Keisuke; Kanegae, Hiroshi

doi:10.1038/s41440-021-00760-9

Cited by 37 publications

(16 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a countrywide survey of Japanese patients, the Kario et al 2022 study looked into patients’ preferences for renal denervation. 21 The study discovered that nearly one-third of the patients preferred RDN, among which patients with resistant hypertension, poor adherence to antihypertensive medications, younger patients, and patients with side effects during antihypertensive treatment were more likely to prefer RDN. 21 A similar study conducted in Germany 22 revealed that RDN was favored by 38.2% of individuals who were not already taking medicine and by 28.2% of those who were.…”

Section: Resultsmentioning

confidence: 99%

“… 21 The study discovered that nearly one-third of the patients preferred RDN, among which patients with resistant hypertension, poor adherence to antihypertensive medications, younger patients, and patients with side effects during antihypertensive treatment were more likely to prefer RDN. 21 A similar study conducted in Germany 22 revealed that RDN was favored by 38.2% of individuals who were not already taking medicine and by 28.2% of those who were. Patients’ preferences were found to be influenced by antihypertensive effects, the experience of side effects, and medication adherence.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

A Systematic Review of Patient Preferences, Expectations, and Values for the Management and Treatment of Hypertension

Xu¹,

Guo²,

Liu³

et al. 2022

PPA

View full text Add to dashboard Cite

Objective To comprehensively summarize the evidence on the preferences, expectations, and values of hypertension management and treatment in hypertensive patients. Methods From inception through January 2022, PubMed, Embase, Web of Science, EBSCO, and China National Knowledge Infrastructure were searched for studies with hypertension value, preference, or expectation. A qualitative retrospective analysis was performed. Results A total of 24 studies involving 8701 participants were included. Although studies on the preferences of hypertensive patients are difficult to standardize, considerable convergence has occurred: 1) Patients preferred treatment regimens with lower incidence of comorbidities, faster response, lower cost, more frequent blood pressure monitoring, fewer side effects, and more convenient medication. 2) Patients have a crucial role in the treatment, and their physicians are expected to develop a shared patient-centered decision-making model. Conclusion The results of this systematic review demonstrated that side effects, cost, and convenience are important factors for patients when selecting a treatment regimen for hypertension. Patients often obtain hypertension information from their physicians and prefer shared patient-centered decision-making.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

A Systematic Review of Patient Preferences, Expectations, and Values for the Management and Treatment of Hypertension

Xu¹,

Guo²,

Liu³

et al. 2022

PPA

View full text Add to dashboard Cite

show abstract

“…The heterogeneous BP responses after RDN were mainly from appropriate patient selection. Patient preference should also be part of the decision-making in patient selection [ 11 ]. The ideal candidates for RDN are patients with autonomic hypersensitivity.…”

Section: Discussionmentioning

confidence: 99%

Long-term outcome of renal nerve denervation (RDN) for resistant hypertension

et al. 2022

View full text Add to dashboard Cite

We aimed to determine the long-term outcome of renal denervation (RDN). All patients with resistant hypertension who underwent RDN between 2012 and 2018 at Siriraj Hospital were included in the study. Patients were followed up at 3, 6, and 12 months and then annually up to 9 years. Effectiveness of the RDN outcome was defined by either (1) a reduction in office systolic BP ≥ 10 mmHg, (2) a reduction in the number of antihypertensive drugs taken, or (3) both outcomes being achieved. In total, 18 RDN procedures were performed during the study period. The mean and longest follow-up periods were 52 months and 104 months, respectively. Heterogeneous BP responses after RDN for resistant hypertension were observed. Effectiveness of the RDN outcome was achieved in 88% of the patients at 1 year and in >80% of the patients during the entire follow-up at each time point up to 9 years.

show abstract

“…Many of these plant metabolites aid in the reduction of oxidative stress, making them potentially useful in the treatment of a wide range of severe illnesses. Despite the availability of numerous medications to treat oxidative stress-related chronic diseases, the high profile of drug side effects necessitates the use of alternative and complementary treatment options for diabetes and cardiovascular diseases (CVDs), such as coronary artery disease (CAD) and blood pressure control [ 2 , 3 ]. To avoid or treat chronic disorders, lifestyle adjustments and dietary interventions, such as increasing fruit and vegetable consumption, are frequently advocated [ 4 , 5 , 6 ].…”

Section: Introductionmentioning

confidence: 99%

Lycopene: A Natural Arsenal in the War against Oxidative Stress and Cardiovascular Diseases

et al. 2022

View full text Add to dashboard Cite

Lycopene is a bioactive red pigment found in plants, especially in red fruits and vegetables, including tomato, pink guava, papaya, pink grapefruit, and watermelon. Several research reports have advocated its positive impact on human health and physiology. For humans, lycopene is an essential substance obtained from dietary sources to fulfil the body requirements. The production of reactive oxygen species (ROS) causing oxidative stress and downstream complications include one of the major health concerns worldwide. In recent years, oxidative stress and its counter strategies have attracted biomedical research in order to manage the emerging health issues. Lycopene has been reported to directly interact with ROS, which can help to prevent chronic diseases, including diabetes and neurodegenerative and cardiovascular diseases. In this context, the present review article was written to provide an accumulative account of protective and ameliorative effects of lycopene on coronary artery disease (CAD) and hypertension, which are the leading causes of death worldwide. Lycopene is a potent antioxidant that fights ROS and, subsequently, complications. It reduces blood pressure via inhibiting the angiotensin-converting enzyme and regulating nitrous oxide bioavailability. It plays an important role in lowering of LDL (low-density lipoproteins) and improving HDL (high-density lipoproteins) levels to minimize atherosclerosis, which protects the onset of coronary artery disease and hypertension. Various studies have advocated that lycopene exhibited a combating competence in the treatment of these diseases. Owing to all the antioxidant, anti-diabetic, and anti-hypertensive properties, lycopene provides a potential nutraceutical with a protective and curing ability against coronary artery disease and hypertension.

show abstract

A Japan nationwide web-based survey of patient preference for renal denervation for hypertension treatment

Cited by 37 publications

References 41 publications

A Systematic Review of Patient Preferences, Expectations, and Values for the Management and Treatment of Hypertension

A Systematic Review of Patient Preferences, Expectations, and Values for the Management and Treatment of Hypertension

Long-term outcome of renal nerve denervation (RDN) for resistant hypertension

Lycopene: A Natural Arsenal in the War against Oxidative Stress and Cardiovascular Diseases

Contact Info

Product

Resources

About